1. Home
  2. PLAB vs BCYC Comparison

PLAB vs BCYC Comparison

Compare PLAB & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • BCYC
  • Stock Information
  • Founded
  • PLAB 1969
  • BCYC 2009
  • Country
  • PLAB United States
  • BCYC United Kingdom
  • Employees
  • PLAB N/A
  • BCYC N/A
  • Industry
  • PLAB Semiconductors
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • BCYC Health Care
  • Exchange
  • PLAB Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • PLAB 1.6B
  • BCYC 1.7B
  • IPO Year
  • PLAB 1987
  • BCYC 2019
  • Fundamental
  • Price
  • PLAB $24.00
  • BCYC $14.68
  • Analyst Decision
  • PLAB Strong Buy
  • BCYC Buy
  • Analyst Count
  • PLAB 1
  • BCYC 9
  • Target Price
  • PLAB $35.00
  • BCYC $35.25
  • AVG Volume (30 Days)
  • PLAB 661.0K
  • BCYC 889.5K
  • Earning Date
  • PLAB 12-11-2024
  • BCYC 02-18-2025
  • Dividend Yield
  • PLAB N/A
  • BCYC N/A
  • EPS Growth
  • PLAB 2.96
  • BCYC N/A
  • EPS
  • PLAB 2.09
  • BCYC N/A
  • Revenue
  • PLAB $866,946,000.00
  • BCYC $36,898,000.00
  • Revenue This Year
  • PLAB N/A
  • BCYC $40.52
  • Revenue Next Year
  • PLAB $9.01
  • BCYC N/A
  • P/E Ratio
  • PLAB $11.50
  • BCYC N/A
  • Revenue Growth
  • PLAB N/A
  • BCYC 48.60
  • 52 Week Low
  • PLAB $20.25
  • BCYC $12.17
  • 52 Week High
  • PLAB $34.16
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 45.27
  • BCYC 28.02
  • Support Level
  • PLAB $25.55
  • BCYC $12.17
  • Resistance Level
  • PLAB $27.08
  • BCYC $17.04
  • Average True Range (ATR)
  • PLAB 1.30
  • BCYC 1.44
  • MACD
  • PLAB -0.18
  • BCYC -0.41
  • Stochastic Oscillator
  • PLAB 7.00
  • BCYC 26.90

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue worldwide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Share on Social Networks: